Methotrexate Before Surgery: What You Need to Know

Undergoing surgery can raise questions about your regular medications—especially when you take methotrexate. This guide explains why methotrexate before surgery matters, what the latest research and guidelines say, and how to work with your care team for the safest possible outcome.

Understanding Methotrexate

Methotrexate is a cornerstone treatment for autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain connective-tissue diseases. It works by:

• Reducing immune activity
• Slowing joint or skin damage
• Controlling inflammation

Because methotrexate affects how your body repairs and fights infection, surgeons and rheumatologists often reassess its use in the days surrounding an operation.

Why Consider Pausing Methotrexate Before Surgery?

The main concerns about continuing methotrexate in the perioperative period are:

• Infection risk: Lowered immunity could mean a higher chance of post-op infections.
• Wound healing: Slower cell growth might delay healing.
• Organ function: Methotrexate can affect liver and kidney function, both of which are crucial for surgery and anesthesia.

However, stopping methotrexate also carries risks: flares of your underlying disease, which can complicate recovery and rehabilitation.

What the Research Says

Several clinical studies have examined outcomes when methotrexate is continued versus paused:

• A randomized trial in rheumatoid arthritis patients undergoing orthopedic surgery found no significant difference in wound healing or infection rates whether methotrexate was stopped or continued.
• Observational data show low-dose methotrexate does not meaningfully increase surgical complications in most elective procedures.
• Severe kidney impairment or very high doses of methotrexate (as used in oncology) carry different risks than the low doses used in rheumatology.

Overall, evidence suggests that for most patients on standard low-dose methotrexate, continuing therapy through surgery does not significantly raise complication rates.

Current Guidelines

Professional societies and expert panels generally recommend:

• Continue methotrexate for most minor and major elective procedures if you have normal liver and kidney function.
• Hold methotrexate only if:
  • You have significant renal impairment (e.g., creatinine clearance < 30 mL/min).
  • You’re on a higher immunosuppressive regimen or additional biologic therapies.
  • You develop signs of bone-marrow suppression (low blood counts).

Always follow the specific advice of your rheumatologist and surgical team, who know your personal health profile.

Factors That Influence the Decision

Every patient and every surgery is different. Key considerations include:

1. Type of Surgery

   • Minor (e.g., skin lesion removal, cataract surgery): usually safe to continue.
   • Major (e.g., joint replacement, abdominal surgery): requires individualized planning.

2. Disease Activity

   • Well-controlled disease lowers the risk of flare if methotrexate is paused.
   • Active inflammation raises both infection risk and potential for flares.

3. Organ Function

   • Normal kidney and liver tests support continuation.
   • Abnormal labs may prompt a temporary hold.

4. Concomitant Medications

   • Steroids, biologics, or other DMARDs can compound immunosuppression.
   • Your team may adjust other drugs rather than methotrexate.

5. Infection History

   • Recurrent infections in the past year may tip the balance toward holding methotrexate.

Practical Steps for Your Surgical Team

Good communication between you, your surgeon, and your rheumatologist is essential. Here’s a sample plan:

• 4–6 Weeks Before Surgery

  • Review all medications, including methotrexate dose and schedule.
  • Check baseline labs (CBC, liver enzymes, creatinine).

• 1–2 Weeks Before Surgery

  • Decide whether to hold methotrexate. If recommended, stopping 7 days before major surgery is common practice.
  • Ensure adequate folic acid supplementation per your provider’s instructions.

• Day of Surgery

  • Bring a complete list of medicines and doses.
  • Confirm antibiotic prophylaxis plan if needed.

Resuming Methotrexate After Surgery

Restarting methotrexate depends on:

• Wound healing: No signs of infection, good closure.
• Lab results: Stable blood counts and organ function.
• Pain and mobility: Able to tolerate oral medications.

Typically, methotrexate may be resumed 7–14 days post-op or once your surgeon gives the green light. Always follow personalized guidance.

Tips for a Smooth Recovery

• Keep your incision clean and dry; watch for redness, swelling, or drainage.
• Report fever, chills, or unusual pain promptly.
• Maintain a balanced diet rich in protein and vitamins to support healing.
• Stay hydrated and follow breathing exercises to prevent complications.
• Attend all follow-up appointments with both your surgeon and rheumatologist.

When to Speak to Your Doctor

While most procedures go smoothly, contact your healthcare provider if you experience:

• High fever (over 38°C/100.4°F) or chills
• Rapid heartbeat or shortness of breath
• Uncontrolled wound pain or new redness and swelling
• Sudden changes in urine output or color

For any life-threatening or serious concern, seek immediate medical attention.

Check Your Symptoms

If you’re unsure whether a symptom is related to methotrexate, surgery, or another cause, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide when to contact your care team or seek urgent care.

---

Discuss any decisions about holding or continuing methotrexate before surgery with your rheumatologist and surgeon. Their guidance, based on your unique health status and the type of operation you need, will help ensure the best possible outcome.